|
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of dyspnea is listed in the xience alpine everolimus eluting coronary stent system, instructions for use as a known patient effect.A conclusive cause for the reported patient effect, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.The rx ultra device is being filed under a separate medwatch mfr number.
|